Cumarinas en especies del género seseli (fam. umbelliferae)

A survey of the coumarins from species of the genus Seseli (Fam. Umbelliferae) is reported.Se presenta una revisión de cumarinas en especies del género Seseli (Fam. Umbelliferae)

Reactividad de 2-acetilhidrazonometil-1-arilimidazol frente a agentes reductores

Catalytic hydrogenation of compounds 1 led mainly to the products resulting of the hydrogenolysis of the bond C=N, while the hydrazides 2 were obtained in small yields using Pd(C) as catalyst. Reduction of la with AlLiH4 yielded the hydrazide 2a for the Z stereoisomer and the products 4a and 5a for the E stereoisomer by hydrogenolysis.La hidrogenación catalítica de los compuestos 1 origina mayoritariamente el producto resultante de la hidrogenolisis del enlace C=N y sólo se obtienen bajos rendimientos de las hidracidas 2 al utilizar Pd(C) como catalizador. La reducción con AlLiH4 de la rinde, para el estereoisómero Z, la hidracida 2a; mientras que el estereoisómero E conduce por hidrogenolisis a los compuestos 4a y 5a

Reactivity of 2-acetylhydrazonemethyl-l -arylimidazole with reducing agents

La hidrogenación catalítica de los compuestos 1 origina mayoritariamente el producto resultante de la hidrogenolisis del enlace C=N y sólo se obtienen bajos rendimientos de las hidracidas 2 al utilizar Pd(C) como catalizador. La reducción con AILiH4 de la rinde, para el estereoisómero Z, la hidracida 2a; mientras que el estereoisómero E conduce por hidrogenolisis a los compuestos 4a y 5a.Catalytic hydrogenation of compounds 1 led mainly to the products resulting of the hydrogenolysis of the bond C=N, while the hydrazides 2 were obtained in small yields using Pd(C) as catalyst. Reduction of la with AILiH. yielded the hydrazide 2a for the Z stereoisomer and the products 4a and 5a for the E stereoisomer by hydrogenolysis

4-(arilaminometil) Imidazol. 1. 1-p-tolil-4-(arilaminometil) imidazol

Se prepara 1-p-tolil-4-(ariliminometil) imidazol (1) por reacción de 1-p-tolil-4-formilimidazol con arilarnina. La reducción de 1 da 1-p-tolil-4-( arilarninometil) imidazol (II). La configuración de I se establece mediante H-RMN

Characterization of microsatellite loci in Erysimum mediohispanicum (Brassicaceae) and cross-amplification in related species

• Premise of the study : We have developed and optimized microsatellite loci from a genomic library of Erysimum mediohispanicum. Microsatellites were also tested for cross-amplifi cation in 31 other Erysimum species. • Methods and Results : A total of 10 microsatellite loci were successfully amplifi ed. They were polymorphic for 81 E. mediohispanicum individuals from two locations in Sierra Nevada (southeastern Spain), which showed similar patterns of genetic diversity. On average, microsatellites had 8.6 alleles per locus and an expected heterozygosity of 0.69. Only one locus signifi cantly departed from Hardy – Weinberg equilibrium in both locations. Most of the markers successfully amplifi ed in other Erysimum species. • Conclusions : The genetic attributes of microsatellite loci will allow their application to population genetic studies in Erysimum , such as genetic differentiation and structure, gene fl ow, pollinator-mediated speciation, and hybridization studies.&nbsp

Inhibidores selectivos de la monoamino oxidasa. 1. Hidracinas de formilimidazoles 1-sustitudos

A series of hydrazinomethylimidazole 1-sustituted was prepared and evaluated for their monoamine oxidase (MAO) inhibitory activity. In vitro testing revealed that the 1-arylimidazole derivatives were selectively inhibitors of MAO A at low concentrations.Se ha preparado una serie de hidracinometilimidazoles 1-sustituidos y estudiado su actividad IMAO. Los ensayos in vitro revelan que los 1-arilimidazoles son inhibidores selectivos de la MAO A a bajas concentraciones

Predictive factors of adherence to frequency and duration components in home exercise programs for neck and low back pain: an observational study

<p>Abstract</p> <p>Background</p> <p>Evidence suggests that to facilitate physical activity sedentary people may adhere to one component of exercise prescriptions (intensity, duration or frequency) without adhering to other components. Some experts have provided evidence for determinants of adherence to different components among healthy people. However, our understanding remains scarce in this area for patients with neck or low back pain. The aims of this study are to determine whether patients with neck or low back pain have different rates of adherence to exercise components of frequency per week and duration per session when prescribed with a home exercise program, and to identify if adherence to both exercise components have distinct predictive factors.</p> <p>Methods</p> <p>A cohort of one hundred eighty-four patients with chronic neck or low back pain who attended physiotherapy in eight primary care centers were studied prospectively one month after intervention. The study had three measurement periods: at baseline (measuring characteristics of patients and pain), at the end of physiotherapy intervention (measuring characteristics of the home exercise program) and a month later (measuring professional behaviors during clinical encounters, environmental factors and self-efficacy, and adherence behavior).</p> <p>Results</p> <p>Adherence to duration per session (70.9% ± 7.1) was more probable than adherence to frequency per week (60.7% ± 7.0). Self-efficacy was a relevant factor for both exercise components (p < 0.05). The total number of exercises prescribed was predictive of frequency adherence (p < 0.05). Professional behaviors have a distinct influence on exercise components. Frequency adherence is more probable if patients received clarification of their doubts (adjusted OR: 4.1; p < 0.05), and duration adherence is more probable if they are supervised during the learning of exercises (adjusted OR: 3.3; p < 0.05).</p> <p>Conclusion</p> <p>We have shown in a clinic-based study that adherence to exercise prescription frequency and duration components have distinct levels and predictive factors. We recommend additional study, and advise that differential attention be given in clinical practice to each exercise component for improving adherence.</p

Active commuting to and from university, obesity and metabolic syndrome among Colombian university students

Background: There is limited evidence concerning how active commuting (AC) is associated with health benefits in young. The aim of the study was to analyze the relationship between AC to and from campus (walking) and obesity and metabolic syndrome (MetS) in a sample of Colombian university students. Methods: A total of 784 university students (78.6% women, mean age = 20.1 ± 2.6 years old) participated in the study. The exposure variable was categorized into AC (active walker to campus) and non-AC (non/infrequent active walker to campus: car, motorcycle, or bus) to and from the university on a typical day. MetS was defined in accordance with the updated harmonized criteria of the International Diabetes Federation criteria. Results: The overall prevalence of MetS was 8.7%, and it was higher in non-AC than AC to campus. The percentage of AC was 65.3%. The commuting distances in this AC from/to university were 83.1%, 13.4% and 3.5% for < 2 km, 2- 5 km and > 5 km, respectively. Multiple logistic regressions for predicting unhealthy profile showed that male walking commuters had a lower probability of having obesity [OR = 0.45 (CI 95% 0.25–0.93)], high blood pressure [OR = 0.26 (CI 95% 0.13–0.55)] and low HDL cholesterol [OR = 0.29 (CI 95% 0.14–0.59)] than did passive commuters. Conclusions: Our results suggest that in young adulthood, a key life-stage for the development of obesity and MetS, AC could be associated with and increasing of daily physical activity levels, thereby promoting better cardiometabolic health.This study was part of the project entitled “Body Adiposity Index and Biomarkers of Endothelial and Cardiovascular Health in Adults”, which was funded by Centre for Studies on Measurement of Physical Activity, School of Medicine and Health Sciences, Universidad del Rosario (Code N° FIUR DNBG001) and Universidad de Boyacá (Code N° RECT 60)

A large multi-country outbreak of monkeypox across 41 countries in the WHO European Region, 7 March to 23 August 2022

Following the report of a non-travel-associated cluster of monkeypox cases by the United Kingdom in May 2022, 41 countries across the WHO European Region have reported 21,098 cases and two deaths by 23 August 2022. Nowcasting suggests a plateauing in case notifications. Most cases (97%) are MSM, with atypical rash-illness presentation. Spread is mainly through close contact during sexual activities. Few cases are reported among women and children. Targeted interventions of at-risk groups are needed to stop further transmission. © 2022 European Centre for Disease Prevention and Control (ECDC). All rights reserved.The authors affiliated with the World Health Organization (WHO) are alone responsible for the views expressed in this publication and they do not necessarily represent the decisions or policies of the WHO. The co-author is a fellow of the ECDC Fellowship Programme, supported financially by the European Centre for Disease Prevention and Control (ECDC). The views and opinions expressed herein do not state or reflect those of ECDC. ECDC is not responsible for the data and information collation and analysis and cannot be held liable for conclusions or opinions drawn